New Delhi, March 31 Novo Nordisk India announced on Tuesday reductions in the prices of Ozempic and Wegovy in India, days after the launch of generic versions of semaglutide injections for patients with type 2 diabetes and obesity.Indian pharmaceutical companies recently announced the launch...
cardiometabolic health
clinicalevidence
diabetes
drug pricing
generic drugs
healthcare costs
india
novo nordisk
obesity
ozempic
pharmaceuticals
semaglutide
treatment
type 2 diabetes
wegovy